ASHLEY HOTARD: Open Payments
NPI 1245752120 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,549 in 89 payments from 18 companies in 2025. Trend: 2023 $975 · 2024 $1,039 · 2025 $1,549
Food & beverage: $1,464Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $407 |
| ABBVIE INC. | 39 | $370 |
| UCB, Inc. | 10 | $138 |
| PFIZER INC. | 4 | $78 |
| Incyte Corporation | 3 | $71 |
| GENZYME CORPORATION | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| LEO Pharma Inc. | 3 | $60 |
| LNHC, Inc | 2 | $48 |
| Amgen Inc. | 2 | $47 |
Products named: TREMFYA, SKYRIZI, RINVOQ, Bimzelx, DUPIXENT, CIBINQO, OPZELURA, ZELSUVMI.
Industry payments across LA — which companies pay providers there.
